Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert C Smallridge

Showing results (41-50 of 67) with videos related to

Pageof 7
Sort By:
International Journal of Molecular Sciences|February 15, 2018
Cytokeratin-8 in Anaplastic Thyroid Carcinoma: More Than a Simple Structural Cytoskeletal ProteinDehuang Guo, Qinqin Xu, Sarabjot Pabla, et al.
Thyroid : Official Journal of the American Thyroid Association|December 18, 2010
Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapyRobert L Foote, Julian R Molina, Jan L Kasperbauer, et al.
Urology|January 1, 2013
Effect of leuprolide on serum amyloid-β peptide levels and memory in patients with prostate cancer with biochemical recurrenceWinston W Tan, Michael G Heckman, Prakash Vishnu, et al.
Thyroid : Official Journal of the American Thyroid Association|November 8, 2012
American Thyroid Association guidelines for management of patients with anaplastic thyroid cancerRobert C Smallridge, Kenneth B Ain, Sylvia L Asa, et al.
Cancer Research|February 12, 2009
Reactivation of suppressed RhoB is a critical step for the inhibition of anaplastic thyroid cancer growthLaura A Marlow, Lisa A Reynolds, Alan S Cleland, et al.
The Journal of Clinical Endocrinology and Metabolism|September 27, 2014
Clinical and molecular features of Hürthle cell carcinoma of the thyroidAna-Maria Chindris, John D Casler, Victor J Bernet, et al.
Journal of Cell Science|June 22, 2012
Foxo3a drives proliferation in anaplastic thyroid carcinoma through transcriptional regulation of cyclin A1: a paradigm shift that impacts current therapeutic strategiesLaura A Marlow, Christina A von Roemeling, Simon J Cooper, et al.
The Journal of Clinical Endocrinology and Metabolism|December 4, 2013
RNA sequencing identifies multiple fusion transcripts, differentially expressed genes, and reduced expression of immune function genes in BRAF (V600E) mutant vs BRAF wild-type papillary thyroid carcinomaRobert C Smallridge, Ana-Maria Chindris, Yan W Asmann, et al.
Frontiers in Endocrinology|December 24, 2024
BRAFV600E/pTERT double mutated papillary thyroid cancers exhibit immune gene suppressionAna-Maria Sigarteu Chindris, Michael Rivera, Yaohua Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2019
Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical StudiesIñigo Landa, Nikita Pozdeyev, Christopher Korch, et al.
Pageof 7

Showing results (41-50 of 67) with videos related to

Sort By:
Pageof 7
International Journal of Molecular Sciences|February 15, 2018
Cytokeratin-8 in Anaplastic Thyroid Carcinoma: More Than a Simple Structural Cytoskeletal ProteinDehuang Guo, Qinqin Xu, Sarabjot Pabla, et al.
Thyroid : Official Journal of the American Thyroid Association|December 18, 2010
Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapyRobert L Foote, Julian R Molina, Jan L Kasperbauer, et al.
Urology|January 1, 2013
Effect of leuprolide on serum amyloid-β peptide levels and memory in patients with prostate cancer with biochemical recurrenceWinston W Tan, Michael G Heckman, Prakash Vishnu, et al.
Thyroid : Official Journal of the American Thyroid Association|November 8, 2012
American Thyroid Association guidelines for management of patients with anaplastic thyroid cancerRobert C Smallridge, Kenneth B Ain, Sylvia L Asa, et al.
Cancer Research|February 12, 2009
Reactivation of suppressed RhoB is a critical step for the inhibition of anaplastic thyroid cancer growthLaura A Marlow, Lisa A Reynolds, Alan S Cleland, et al.
The Journal of Clinical Endocrinology and Metabolism|September 27, 2014
Clinical and molecular features of Hürthle cell carcinoma of the thyroidAna-Maria Chindris, John D Casler, Victor J Bernet, et al.
Journal of Cell Science|June 22, 2012
Foxo3a drives proliferation in anaplastic thyroid carcinoma through transcriptional regulation of cyclin A1: a paradigm shift that impacts current therapeutic strategiesLaura A Marlow, Christina A von Roemeling, Simon J Cooper, et al.
The Journal of Clinical Endocrinology and Metabolism|December 4, 2013
RNA sequencing identifies multiple fusion transcripts, differentially expressed genes, and reduced expression of immune function genes in BRAF (V600E) mutant vs BRAF wild-type papillary thyroid carcinomaRobert C Smallridge, Ana-Maria Chindris, Yan W Asmann, et al.
Frontiers in Endocrinology|December 24, 2024
BRAFV600E/pTERT double mutated papillary thyroid cancers exhibit immune gene suppressionAna-Maria Sigarteu Chindris, Michael Rivera, Yaohua Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 10, 2019
Comprehensive Genetic Characterization of Human Thyroid Cancer Cell Lines: A Validated Panel for Preclinical StudiesIñigo Landa, Nikita Pozdeyev, Christopher Korch, et al.
Pageof 7